Navigation Links
Ludwig cancer researchers honored among first class of fellows in AACR Academy
Date:3/26/2013

March 26, 2013, New York, NY Three Ludwig scientists were named as Fellows in the inaugural class of the AACR Academy, the most prestigious honor bestowed by the American Association for Cancer Research.

The first class of Fellows includes Webster K. Cavenee, PhD, Director, Ludwig Institute for Cancer Research at the University of California San Diego; Bert Vogelstein, MD, Director, Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins University; and Robert A. Weinberg, PhD, Director, Ludwig/MIT Center for Molecular Oncology.

"Each of these researchers has pioneered advancements in cancer research. They have helped to transform the landscape by enhancing the understanding of the underlying causes of cancer and accelerating the development of new tools to defeat it," said Edward A. McDermott, Jr., President and Chief Executive Officer, Ludwig Institute for Cancer Research. "We are grateful for the recognition by AACR of the life work of these researchers."

The 106 Fellows who comprise the inaugural class were selected by their peers for their extraordinary contributions to the cancer field and will be inducted on April 5, 2013. The AACR Academy was created to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer.


'/>"/>
Contact: Rachel Steinhardt
rsteinhardt@licr.org
212-450-1582
Ludwig Institute for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
2. Embryonic development protein active in cancer growth
3. BRG1 mutations confer resistance to hormones in lung cancer
4. Genetic variation in East Asians found to explain resistance to cancer drugs
5. Beyond the microscope: Identifying specific cancers using molecular analysis
6. Marshall University study may lead to new treatments for prostate cancer
7. Salk scientists open new window into how cancers override cellular growth controls
8. Penn research points to new way of preserving fertility for boys undergoing cancer treatment
9. Genetic abnormality offers diagnostic hope for childrens cancer
10. Protein jailbreak helps breast cancer cells live
11. Breast cancer risk gene discovery fast tracked by new technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... ... December 03, 2016 , ... Microbial genomics leader uBiome is ... has been made to Dr. Renato Polimanti of Yale University School of Medicine, ... microbiome. Grant proposals have been vetted by the company’s scientific review committee. ...
(Date:12/2/2016)... ... December 02, 2016 , ... In ... cervical and lumbar disc production, company President, Jake Lubinski will be traveling to ... the AxioMed disc in Bern, Lucerne, and Zurich to discuss the benefits of ...
(Date:12/2/2016)... Dec. 2, 2016 Amgen (NASDAQ: AMGN ... announced the submission of a Marketing Authorization Application (MAA) to ... candidate to Avastin ® (bevacizumab). The companies believe this ... EMA. "The submission of ABP 215 to ... expand our oncology portfolio," said Sean E. Harper , ...
(Date:12/2/2016)... , ... December 01, 2016 , ... ACEA Biosciences, Inc. ... Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, ... an update on the phase I/II clinical trials for AC0010 in patients with advanced ...
Breaking Biology Technology: